Carey Danis & Lowe | Attorneys at Law
  • Home
  • Our Attorneys
    • About Carey Danis & Lowe
  • Featured Cases
  • Practice Areas
    • Antitrust
    • Class Actions
      • AT&T Cell Phone Bill Cramming
      • AT&T Telephone Bill Cramming
      • Credit Card Payment Protection
    • Defective & Faulty Medical Device Litigation
      • Guidant Defibrillator
      • Hip & Knee Replacement
      • Ob Tape & Slings
      • Transvaginal Mesh
    • Medical Malpractice
    • Personal Injury
      • Truck & Car Accidents
    • Pharmaceutical Litigation
      • Accutane®
      • Actos®
      • Asbestos Mesothelioma
      • Avandia®
      • Celexa®
      • Levaquin®
      • Lexapro®
      • Luvox®
      • Mirena®
      • NuvaRing®
      • Paxil®
      • Pradaxa®
      • Prozac®
      • Symbyax®
      • Topamax®
      • Wellbutrin®
      • Yaz® Yasmin®
      • Zoloft®
    • Product Liability
    • Securities Fraud
    • Unfair & Deceptive Trades
  • Firm News
    • Firm Resume
    • Press Release
    • Testimonials
  • Contact Us
    • via Email
    • via Facebook
    • via LinkedIn
    • via Twitter
    • via RSS
  • Blog
Like Carey Danis & Lowe on FacebookConnect With Carey Danis & Lowe on LinkedInFollow Carey Danis & Lowe on TwitterSubscribe to Carey Danis & Lowe via RSS

  P.  800.721.2519
 Ask a Nurse

small http://grotpaydayloans.com

Contraceptive Nuvaring Linked to Blood Clots and Stroke

Published November 12, 2012 by LawsuitInformation.org Nuvaring is a contraceptive device manufactured by Organon. It was approved by the U.S. Food and Drug Administration (FDA) in 2001. Organon developed and manufactured Nuvaring on the premise of introducing a new form of birth control, one that would supposedly be easier for women to use. However, it soon became apparent after the release of Nuvaring that there were serious issues with the contraceptive device. Questions began to arise as to the verity of Organon’s marketing campaign promoting Nuvaring, especially regarding third-generation Continue Reading

Federal Trade Commission Concludes Investigation into Bayer Pharmaceuticals and Yasmin Patent Litigation

Published October 12, 2012 by LawsuitInformation.org In recent news regarding Bayer Pharmaceuticals, the German pharmaceutical giant responsible for the manufacture of Yaz and Yasmin, the Federal Trade Commission made the decision to terminate its investigation into a patent settlement between Bayer and Teva Pharmaceuticals. In 2008, the two pharmaceutical companies reached an agreement in regards to Bayer’s claim that Barr Laboratories, which was ultimately purchased by Teva Pharmaceuticals, overstepped the boundaries of intellectual property protecting Bayer’s Yasmin patent. The 2008 settlement drew the attention of the FTC, and led Continue Reading

Yaz/Yasmin DVT & Pulmonary Embolism Settlements Progressing

Published July 10, 2012 by LawsuintInformation As a Yaz Pulmonary Embolism, Deep Vein Thrombosis Attorney I have written extensively about the risks inherent in birth control pills containing Drospirenone. According to status report held on June 22, in the U.S. District Court for the Southern District of Illinois, Bayer has reached agreements with about 33 different law firms to resolve at least 1,444 Yaz Deep Vein Thrombosis, Stroke and Pulmonary Embolism claims. According to Bloomberg News, as of late April, Bayer faced 11,900 lawsuits over Yaz and its sister Continue Reading

34 Plaintiffs Fill New Yaz and Yasmin Lawsuit

Published May 19, 2012 on Seedol In addition to the nearly 12,000 Yaz and Yasmin Lawsuits that have been filed a new Yaz Lawsuit and Yasmin Lawsuit was filed in the Superior Court of California, Los Angeles County in late April. This new Y Lawsuit names Bayer Healthcare LLC; Bayer Pharmaceuticals Corporation; Bayer Healthcare Pharmaceuticals Inc.; Berlex Laboratories, Inc.; Berlex, Inc.; Bayer Schering Pharma AG; Bayer AG; McKesson Corporation; Barr Laboratories, Inc; Barr Pharmaceuticals LLC; Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd as defendants. The Yaz Lawsuit Continue Reading

  • Featured Cases & Current Litigation

    • Vaginal Mesh Litigation
    • Topamax® Birth Defects
    • Lexapro® & Birth Defects
    • Pradaxa® Internal Bleeding
    • Prozac® & Birth Defects
    • Yaz® & Yasmin® Blood Clots
    • Transvaginal Mesh Injury
    • Paxil® & Birth Defects
    • NuvaRing® Blood Clots
    • Mirena® IUD Complications
    • Asbestos Mesothelioma
    • Trucking Accidents & Passenger Vehicle Collision Settlements
  • Recent Posts & News Articles

    • NuvaRing Lawsuit News from Carey Danis & Lowe NuvaRing Law Firm: Seven Cases Removed from NuvaRing Multicounty Litigation in New Jersey
    • Carey Danis & Lowe Actos Lawyers Comment on Annulled Cooper v. Takeda Compensatory Award
    • Chicago DePuy Hip Trial Jury Rules in Favor of Johnson & Johnson and DePuy
    • Cooper v. Takeda Jury Presented with Plaintiff Closing Argument Linking Actos and Bladder Cancer
    • Bayer Loses Yaz Patent in Federal Court of Appeals: Generic Yaz Versions Begin (Stealing) Marketshare
    • Carey Danis & Lowe Pradaxa Lawyers Currently Following Pradaxa MDL 2385
    • FDA Approves New Anticoagulation Reversal Agent and Boehringer Ingelheim Updates Pradaxa Label
    • Carey Danis & Lowe Actos Cancer Lawyers Optimistic Following Cooper v. Takeda $6.5 Million Compensatory Award
Our Offices
Saint Louis, Missouri
8235 Forsyth Ste 1100
St. Louis, MO 63105
T. 314 725 7700
F. 314 721 0905
Godfrey, Illinois
5512 Godfrey Road
Godfrey, IL 62035
T. 618 463 0644
F. 314 721 0905
Belleville, Illinois
5111 W. Main Street
Belleville, IL 62226
T. 618 212 6300
F. 314 721 0905
Vero Beach, Florida
612 Beachland Blvd
Vero Beach, FL 32963
T. 314 725 7700
F. 314 721 0905
© 2013 Carey Danis & Lowe
reVisioned.by
Toll Free P. 800-721-2519
Home • Contact • About